Qualys, Inc.
$5.78B- Market cap
- $5.94B
- Debt
- +$95.20M
- Cash
- −$250.26M
Capital structure 98% equity / 2% debt · EV / Revenue 8.64x · EV / EBITDA 23.19x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $5.94B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · View financials
Decision snapshot: QLYS stock price vs EXAS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EXAS's multiple
Needs EXAS P/E.
Implied fair value · at QLYS's multiple
Needs EPS (TTM) is negative, QLYS P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: QLYS FY 2025 (ended Dec 31, 2025) · EXAS FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 98% equity / 2% debt · EV / Revenue 8.64x · EV / EBITDA 23.19x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Qualys, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
EXACT SCIENCES CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.17x
1.19x
Net debt / EBITDA
Leverage against operating earnings
-0.62x
35.68x
Cash and equivalents
Liquid reserves on the balance sheet
$250.26M
$964.71M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CrowdStrike Holdings, Inc.
QLYS vs CRWD
Okta, Inc.
QLYS vs OKTA
Gen Digital Inc.
QLYS vs GEN
Palo Alto Networks Inc
QLYS vs PANW
Fortinet, Inc.
QLYS vs FTNT
Zscaler, Inc.
QLYS vs ZS
Guardant Health, Inc.
QLYS vs GH
Natera, Inc.
QLYS vs NTRA
NEOGENOMICS INC
QLYS vs NEO
OPKO HEALTH, INC.
QLYS vs OPK
LABCORP HOLDINGS INC.
QLYS vs LH
QUEST DIAGNOSTICS INC
QLYS vs DGX
$95.20M
$2.85B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.